Atlas Trials

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer

Clinical trial NCT03511664 · COMPLETED

Trial details

NCT number
NCT03511664
Sponsor
Endocyte
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2018-05-29
Primary completion
2021-01-27
Enrollment
861

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.